{
  "guideline_id": "I.C.19.e.2",
  "semantic_title": "Use Multiple Codes to Completely Describe All Drugs, Medicinal or Biological Substances",
  "section_path": "Section I > C. Chapter-Specific Coding Guidelines > 19. Injury, Poisoning, and Certain Other Consequences of External Causes > e. Adverse Effects, Poisoning, Underdosing and Toxic Effects > 2. Use as many codes as necessary to describe",
  "page_number": 82,
  "content": {
    "full_text": "Use as many codes as necessary to describe completely all drugs, medicinal or biological substances. (Evidence: pg no: 82, L37-L38)",
    "summary": "Instruction to assign multiple codes as needed to fully document all drugs, medicinal agents, or biological substances involved in adverse effects, poisoning, or underdosing (Evidence: pg no: 82, L37-L38)",
    "key_concepts": [
      "Multiple code assignment requirement (Evidence: pg no: 82, L37)",
      "Complete description mandate (Evidence: pg no: 82, L37-L38)",
      "All substances documentation (Evidence: pg no: 82, L38)"
    ],
    "detailed_rules": [
      {
        "rule_id": "MULTIPLE_CODES_COMPLETE_DESCRIPTION",
        "rule_text": "Use as many codes as necessary to describe completely all drugs, medicinal or biological substances (Evidence: pg no: 82, L37-L38)",
        "explanation": "When multiple substances are involved in an adverse effect, poisoning, underdosing, or toxic effect, each substance should be coded separately to provide complete documentation (Evidence: pg no: 82, L37-L38)",
        "importance": "high",
        "applies_to": "T36-T65",
        "common_applications": [
          "Multiple drug interactions",
          "Polypharmacy adverse effects",
          "Complex poisoning cases",
          "Multiple substance exposures"
        ]
      }
    ],
    "workflow_steps": [
      "Step 1: Identify all drugs, medicinal, or biological substances involved",
      "Step 2: Determine the effect/condition for each substance",
      "Step 3: Assign appropriate code for each substance",
      "Step 4: Verify complete documentation of all substances",
      "Step 5: Ensure no substances are omitted from coding"
    ],
    "related_terminology": [
      "Multiple codes",
      "Complete description",
      "Drugs",
      "Medicinal substances",
      "Biological substances",
      "Comprehensive coding"
    ]
  },
  "code_references": {
    "code_ranges": [
      {
        "range": "T36-T65",
        "description": "Categories requiring complete substance documentation (Evidence: pg no: 82, L37-L38)",
        "requirement": "Use multiple codes as necessary for complete description",
        "usage_rules": [
          "Code each substance separately (Evidence: pg no: 82, L37-L38)",
          "Ensure complete documentation of all involved substances (Evidence: pg no: 82, L37-L38)"
        ]
      }
    ],
    "specific_codes": [],
    "code_patterns": [
      {
        "pattern": "Multiple substance codes",
        "description": "Separate codes for each drug/substance involved (Evidence: pg no: 82, L37-L38)",
        "example": "T36.0X5- + T39.1X5- for multiple drug adverse effects",
        "explanation": "Complete documentation requires individual coding of each substance (Evidence: pg no: 82, L37-L38)"
      }
    ],
    "code_categories_mentioned": [
      "T36-T65 drug and substance codes"
    ]
  },
  "cross_references": {
    "references_to": [],
    "referenced_by": []
  },
  "coding_scenarios": [
    {
      "scenario_id": "MULTIPLE_DRUG_ADVERSE_EFFECTS",
      "scenario": "Patient has adverse reactions to multiple prescribed medications",
      "documentation_example": "Patient developed nausea from metformin and rash from lisinopril",
      "step_by_step": [
        "Step 1: Identify all substances (metformin, lisinopril)",
        "Step 2: Identify effects (nausea, rash)",
        "Step 3: Code nausea as nature of adverse effect",
        "Step 4: Code rash as nature of adverse effect",
        "Step 5: Code metformin adverse effect",
        "Step 6: Code lisinopril adverse effect"
      ],
      "correct_coding": {
        "primary_code": "Code for nausea",
        "secondary_codes": [
          "Code for rash",
          "Metformin adverse effect code",
          "Lisinopril adverse effect code"
        ],
        "sequencing": "Nature of adverse effects first, then drug codes",
        "rationale": "Complete description requires coding all substances involved (Evidence: pg no: 82, L37-L38)"
      },
      "incorrect_coding": {
        "code": "Coding only one substance",
        "codes": [
          "Single drug code only"
        ],
        "rationale": "Incomplete documentation of all involved substances",
        "common_mistake": "Omitting some substances in multiple drug scenarios"
      }
    }
  ],
  "procedure_links": [],
  "examples": [
    {
      "example_id": "COMPREHENSIVE_SUBSTANCE_CODING",
      "scenario": "Multiple substances requiring individual codes",
      "code_example": "Separate codes for each substance",
      "breakdown": {
        "Substance 1": "Individual code for first drug/substance (Evidence: pg no: 82, L37-L38)",
        "Substance 2": "Individual code for second drug/substance (Evidence: pg no: 82, L37-L38)",
        "Additional": "Continue for all substances involved (Evidence: pg no: 82, L37-L38)"
      },
      "rationale": "Complete description mandate requires individual coding of each substance (Evidence: pg no: 82, L37-L38)"
    }
  ],
  "special_notes": {
    "warnings": [
      "Do not omit any drugs, medicinal, or biological substances (Evidence: pg no: 82, L37-L38)"
    ],
    "best_practices": [
      "Code each substance individually for complete documentation (Evidence: pg no: 82, L37-L38)",
      "Review documentation to ensure all substances are identified and coded"
    ],
    "common_mistakes": [
      "Coding only the primary or most significant substance",
      "Omitting substances in complex cases",
      "Incomplete substance documentation"
    ],
    "tips": [
      "Complete description is the goal (Evidence: pg no: 82, L37-L38)",
      "Each substance deserves individual coding consideration"
    ],
    "implementation_notes": [
      "Important for drug interaction analysis",
      "Critical for comprehensive adverse event documentation",
      "Supports pharmacovigilance efforts"
    ],
    "clinical_context": [
      "Essential for polypharmacy management",
      "Important for drug safety monitoring",
      "Critical for complex medication regimens"
    ]
  },
  "search_keywords": [
    "multiple codes",
    "complete description",
    "all drugs",
    "medicinal substances",
    "biological substances",
    "comprehensive coding"
  ],
  "metadata": {
    "category": "chapter_specific",
    "subcategory": "adverse_effects_poisoning",
    "complexity_level": "intermediate",
    "applies_to_settings": [
      "inpatient",
      "outpatient"
    ],
    "last_updated": "FY 2026",
    "tags": [
      "multiple_codes",
      "drugs",
      "substances",
      "complete_description",
      "T36-T65"
    ]
  },
  "page_range_processed": "pages_81_to_84"
}